20
Participants
Start Date
March 2, 2017
Primary Completion Date
March 2, 2019
Study Completion Date
March 2, 2019
HD-MTX-Ara-C regimen
"HD-MTX-Ara-C regimen high-does metrotrexate 3.5g/m2 d1 ivgtt 6h,cytarabine~1g/m2 bid d2-3.Continued use to the end of chemotherapy .Every 21 days for one cycle and four cycles are required. Efficacy was evaluated every two cycles"
FTD regimen
FTD regimen(fotemustine, temozolomide and dexamethasone),fotemustine 100mg/m2 d1 ivgtt,temozolomide 150mg/m2 d1-5 po,dexamethasone 40mg d1-5 ivgtt.Continued use to the end of chemotherapy .Every 28 days for one cycle and four cycles are required. Efficacy was evaluated every two cycles
Oncology Department of The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Zhengzhou University
OTHER
Mingzhi Zhang
OTHER